12 Ulcerative Colitis Clinical Trials in Tucson, AZ (2026)

Q: How do I join a clinical trial in Tucson?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you.

Recruiting Ulcerative Colitis Studies in Tucson

NCT00358943Recruiting

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatme...

Tucson, AZ12,000 participantsGenzyme, a Sanofi Company

View Study Details

NCT05489705Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

This registry evaluates patient characteristics, real-world treatment patterns, and short- and long-term outcomes in a population of patients in the United States and Europe with symptomatic obstructi...

Tucson, AZ1,700 participantsBristol-Myers Squibb

View Study Details

NCT06729775Recruiting

Disentangling the Role of Culture, Life Stage, and Information Design to Facilitate Equity in Data Report Back

There remains a need for novel research that facilitates RBRR in a manner that raises data and environmental health literacy (D/EHL) and supports communities striving for environmental health and stru...

Tucson, AZNA1,546 participantsUniversity of Arizona

View Study Details

NCT07184996Recruiting

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, Phase 3 induction study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely...

Tucson, AZPHASE3980 participantsSanofi

View Study Details

NCT07190222Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged...

Tucson, AZPHASE3942 participantsSanofi

View Study Details

NCT04333537Recruiting

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

This phase II/III trial studies how well sentinel lymph node biopsy works and compares sentinel lymph node biopsy surgery to standard neck dissection as part of the treatment for early-stage oral cavi...

Tucson, AZPHASE2686 participantsNRG Oncology

View Study Details

NCT07185009Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcera...

Tucson, AZPHASE3671 participantsSanofi

View Study Details

NCT07280468Recruiting

Endotype DIrected Treatment for OSA in Down Syndrome

Down syndrome is the most common genetic cause of intellectual disability. People with Down syndrome often have obstructive sleep apnea (OSA), a condition where people have difficulties with breathing...

Tucson, AZPHASE4200 participantsUniversity of Arizona

View Study Details

NCT05988385Recruiting

The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults Study

The Effects of Successful OSA TreatmENT on Memory and AD BIomarkers in Older AduLts (ESSENTIAL) study is a 5-year, multicenter randomized open-label trial that will screen 400 cognitively normal older...

Tucson, AZNA200 participantsCalifornia Pacific Medical Center Research Institute

View Study Details

NCT06556654Recruiting

Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)

The GORE Tissue Reinforcement for Breast Reconstruction (TRBR) research study will look at breast reconstruction during mastectomy procedures. There will be two arms in this study, a Treatment Arm, wh...

Tucson, AZNA180 participantsW.L.Gore & Associates

View Study Details

NCT02717039Recruiting

Pharmacogenomics of Heparin-Induced Thrombocytopenia

The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin. Heparin is commonly used to prevent...

Tucson, AZ125 participantsUniversity of Arizona

View Study Details

NCT05076175Recruiting

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

The purpose of this study is to evaluate the effectiveness and safety of ozanimod (RPC1063) in achieving and maintaining clinical remission. Ozanimod will be administered orally to pediatric participa...

Tucson, AZPHASE2120 participantsBristol-Myers Squibb

View Study Details

About Ulcerative Colitis Clinical Trials in Tucson

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 12 ulcerative colitis clinical trials recruiting participants in Tucson, AZ. These studies are seeking a combined 19,350 participants. Research is being sponsored by Genzyme, a Sanofi Company, Bristol-Myers Squibb, University of Arizona and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Tucson — FAQ

Are there ulcerative colitis clinical trials in Tucson?

Yes, there are 12 ulcerative colitis clinical trials currently recruiting in Tucson, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 12 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated July 18, 2026 from ClinicalTrials.gov